MPA and MIA collaboration
7 November 2019
In a boost for melanoma patients across the country, Melanoma Patients Australia and Melanoma Institute Australia have announced a new multi-year agreement to provide enhanced support services for patients nationally. The agreement was announced at a Melanoma Information Forum held in Sydney, jointly hosted by both organisations. The forum detailed updates on treatments, surgery and strategies for living well and included expert advice from MIA Co-Medical Directors Professor Georgina Long and Professor Richard Scolyer.
The new MPA/MIA agreement will focus on:
- Introduction of a Tele Health Nurse Pilot Program to provide better access of services for melanoma patients
- Increased capacity and expertise of MPA’s Peer to Peer volunteer facilitators and volunteer support staff
- Enhanced face to face support groups within NSW and integration of these into MPA’s national support network
- Joint involvement in events including patient information sessions and MIA’s national Melanoma March campaign.
‘Both organisations look forward to partnering more closely to deliver enhanced support services to melanoma patients nationally,’ said Matthew Browne, CEO of Melanoma Institute Australia.
‘We are very excited and proud to be working with the incredible team at Melanoma Institute Australia,’ said Victoria Beedle, CEO of Melanoma Patients Australia. ‘MIA’s goal is zero deaths from melanoma achieved through research into new and exciting treatments for patients. With survival rates continuing to improve, the need for this collaboration to strengthen the Support Services available to our patients and families, is, thankfully, even greater. With this partnership we will achieve national synergies and strength from our collective efforts to raise awareness of melanoma in the community.’
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.
It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.
Weekend two hit the ground marching with Melanoma Marches in Wollongong, Townsville, Mandurah and Western Sydney.